Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 4:22 pm Sale |
2025-04-11 | 13G | Aspire BioPharma, Inc. ASBP |
Lance Friedman | 4,051,733 8.280% |
-131,642 (-3.15%) |
Filing History |
| 2025-04-11 4:55 pm Sale |
2025-04-04 | 13G | Aspire BioPharma, Inc. ASBP |
Lance Friedman | 4,183,375 8.550% |
-209,500 (-4.77%) |
Filing History |
| 2025-04-04 5:28 pm Sale |
2025-03-26 | 13G | Aspire BioPharma, Inc. ASBP |
Lance Friedman | 4,392,875 8.980% |
-46,500 (-1.05%) |
Filing History |
| 2025-03-28 5:29 pm Sale |
2025-03-19 | 13G | Aspire BioPharma, Inc. ASBP |
Lance Friedman | 4,439,375 9.078% |
-170,000 (-3.69%) |
Filing History |
| 2025-03-20 9:58 pm Sale |
2025-03-03 | 13G | Aspire BioPharma, Inc. ASBP |
Lance Friedman | 4,609,375 9.462% |
-195,000 (-4.06%) |
Filing History |
| 2025-03-12 4:05 pm Sale |
2025-03-03 | 13G | Aspire BioPharma, Inc. ASBP |
Lance Friedman | 4,804,375 9.825% |
-79,000 (-1.62%) |
Filing History |
| 2025-02-26 9:20 pm Purchase |
2025-02-17 | 13G | Aspire BioPharma, Inc. ASBP |
Lance Friedman | 4,883,375 9.980% |
4,883,375 (New Position) |
Filing History |